Evaluation of liver fibrosis: a concise review (Q35794328)

10 August 2017

1 reference

title

Evaluation of liver fibrosis: a concise review (English)

1 reference

10 August 2017

David Nunes

2

0 references

Nezam Afdhal

object named as

Nezam H Afdhal

series ordinal

1

0 references

language of work or name

English

0 references

publication date

1 June 2004

1 reference

The American Journal of Gastroenterology

10 August 2017

1 reference

10 August 2017

99

1 reference

10 August 2017

6

1 reference

10 August 2017

1160-1174

1 reference

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Sampling Variability on Percutaneous Liver Biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Intra-observer and inter-observer variation in the histopathological assessment of chronic viral hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Collagen synthesis by human liver (myo)fibroblasts in culture: evidence for a regulatory role of IL-1 beta, IL-4, TGF beta and IFN gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Vitronectin in the cirrhotic liver: an immunomarker of mature fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Progressive viral-induced cirrhosis: serial MR imaging findings and clinical correlation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Prothrombin index is an indirect marker of severe liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Leptin is essential for the hepatic fibrogenic response to chronic liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum hyaluronan as a marker of liver fibrosis in hemophiliacs with hepatitis C virus-associated chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Extracellular matrix degradation and the role of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Effect of antiviral therapy on markers of fibrogenesis in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Transforming growth factor-beta 1 in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Integrin up-regulation in chronic liver disease: relationship with inflammation and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Kinetics of serum cytokines reflect changes in the severity of chronic hepatitis C presenting minimal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

The utility of radiological imaging in nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C. Relationship to interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2004.30110.X

Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.3109/00365528309181554

Reproducibility of liver biopsy diagnosis in relation to the size of the specimen

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.3109/00365528009181479

Identifiers

DOI

10.1111/J.1572-0241.2004.30110.X

1 reference

10 August 2017

1 reference

PubMed ID

15180741